Sale!

USH1C Gene Deafness Autosomal Recessive Type 18 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The USH1C Gene Deafness Autosomal Recessive Type 18 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the USH1C gene, which are linked to a form of deafness known as Autosomal Recessive Non-Syndromic Sensorineural Deafness Type 18. This condition is characterized by the congenital loss of hearing that occurs due to genetic mutations inherited from both parents. The test is crucial for early diagnosis, which can significantly aid in managing the condition through interventions such as hearing aids, cochlear implants, or other supportive therapies tailored to the patient’s needs.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the USH1C gene. The precision and reliability of the testing process at DNA Labs UAE ensure that individuals and families receive accurate genetic information, which is essential for understanding the risk of passing the condition to future generations and exploring possible treatments.

The cost of the USH1C Gene Deafness Autosomal Recessive Type 18 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive process of genetic analysis and the provision of a detailed report, which includes interpretation of the results by qualified genetic counselors. This service is invaluable for affected individuals and their families, providing them with the necessary information to make informed decisions about their health and well-being.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Genetic Lab Blog: USH1C Gene Deafness autosomal recessive type 18 Genetic Test cost AED:4400.0 symptoms diagnosis

Test Name: USH1C Gene Deafness autosomal recessive type 18 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB7

Test Details: USH1C Gene Deafness, autosomal recessive type 18 is a genetic condition that causes both hearing loss and vision impairment. It is caused by mutations in the USH1C gene, which is involved in the development and function of the inner ear and retina. NGS Genetic Test refers to Next-Generation Sequencing, a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA. In the context of USH1C Gene Deafness, autosomal recessive type 18, an NGS Genetic Test would involve sequencing the USH1C gene to identify any mutations or variations that may be causing the condition. This type of genetic testing can help diagnose individuals with USH1C Gene Deafness, autosomal recessive type 18 and provide information about the specific genetic cause of their condition. It can also be used for carrier testing to determine if individuals are carriers of the mutated gene and may pass it on to their children. NGS Genetic Testing for USH1C Gene Deafness, autosomal recessive type 18 can be beneficial for individuals and families affected by the condition, as it can provide a more accurate diagnosis, guide treatment options, and help with family planning decisions. It is typically performed by a medical geneticist or genetic counselor, who can interpret the results and provide appropriate recommendations based on the findings.

Test Name USH1C Gene Deafness autosomal recessive type 18 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB7
Test Details

USH1C Gene Deafness, autosomal recessive type 18 is a genetic condition that causes both hearing loss and vision impairment. It is caused by mutations in the USH1C gene, which is involved in the development and function of the inner ear and retina.

NGS Genetic Test refers to Next-Generation Sequencing, a high-throughput sequencing technology that allows for the rapid and efficient sequencing of large amounts of DNA. In the context of USH1C Gene Deafness, autosomal recessive type 18, an NGS Genetic Test would involve sequencing the USH1C gene to identify any mutations or variations that may be causing the condition.

This type of genetic testing can help diagnose individuals with USH1C Gene Deafness, autosomal recessive type 18 and provide information about the specific genetic cause of their condition. It can also be used for carrier testing to determine if individuals are carriers of the mutated gene and may pass it on to their children.

NGS Genetic Testing for USH1C Gene Deafness, autosomal recessive type 18 can be beneficial for individuals and families affected by the condition, as it can provide a more accurate diagnosis, guide treatment options, and help with family planning decisions. It is typically performed by a medical geneticist or genetic counselor, who can interpret the results and provide appropriate recommendations based on the findings.